Skip to main content


Guideline Updates

NCCN released an update to its clinical practice guideline for SCLC, including modifications for supportive care and…
NCCN released an update to its clinical practice guideline for kidney cancer, featuring updates to first-line and…
NCCN released an update to its clinical practice guideline for central nervous system cancers, adding lorlatinib as a…
NCCN updated its clinical practice guideline for bladder cancer, removing atezolizumab as an alternative second-line…
NCCN released an update to its clinical practice guideline for B-cell lymphomas, featuring updates for follicular…
NCCN released an update to its clinical practice guideline for multiple myeloma, adding melphalan flufenamide/…
NCCN released an update to its clinical practice guideline for breast cancer, featuring extensive updates for invasive…
NCCN released an update to its clinical practice guideline for gastric cancer, including updates to second-line or…
NCCN released an update to its clinical practice guideline for esophageal and esophageal junction cancers, adding fam-…
ASCO released an update to its guideline on systemic therapy for patients with stage IV NSCLC with driver alterations.
Back to Top